CompletedPhase 4

Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles

United States30 participantsStarted 2021-12-08

Plain-language summary

This study is being conducted to improve standards of care in the cosmetic treatment of sun damage, fine lines, and wrinkles. VI Peels® and Botox® have been used cosmetically to improve patient concerns as monotherapies. This study seeks to confirm that the same-day combination creates no additional side-effects and furthermore that patient satisfaction is heightened as a result.

Who can participate

Age range30 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy Female and Males subjects of any race
✓. Ages 30-70 Years old
✓. Subjects who can read, understand, and sign the Informed Consent Form.
✓. Subjects willing and able to comply with all study requirements, including return visits and photographs (eyes censored or uncensored).

Exclusion criteria

✕. Is pregnant or lactating
✕. Has an active infection on their face (excluding acne)
✕. Has used Isotretinoin (Accutane) within the last six months
✕. Has had chemotherapy or radiation treatments within the last six months
✕. Has a history of neuromuscular disorders
✕. Has a history of bleeding disorders
✕. Has an allergy to albumin
✕. Has an allergy to Aspirin

What they're measuring

Incidence of Treatment-Emergent Adverse Events

Timeframe: Day 7 (+/- 3)

Trial details

NCT IDNCT05162300

SponsorVitality Institute Medical Products

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-01-13

View on ClinicalTrials.gov More Photoaging trials